Crohn's

In less than a year’s time, 23andMe is more than halfway to its goal of enrolling 10,000 patients in its study of Inflammatory Bowel Disease (IBD), which will look more...

Over the summer 23andMe launched a collaborative study with Pfizer to study the research inflammatory bowel disease (IBD). We’ve been encouraged by the number of people diagnosed with either Crohn’s...

This summer 23andMe launched a new research initiative to study Inflammatory Bowel Disease. 23andMe has the good fortune to be collaborating with Pfizer on this study. Pfizer brings a wealth...

It might not be genetic but there appears to be a clear association between having inflammatory bowel disease and having a damn good sense of humor. IBD is a serious...

For people battling Inflammatory Bowel Disease – an umbrella diagnosis that includes serious digestive conditions such as Crohn’s disease or ulcerative colitis – it’s easy to feel isolated and alone....

DNA testing reveals how Ashkenazi Jewish ancestry is genetically distinct from European ancestry. Although Ashkenazi Jews fall under the umbrella of “European,” it’s clear from numerous studies that they’re genetically unique and distinct from the European population at large.

Inflammatory  bowel disease (IBD) is a chronic autoimmune disorder — encompassing both Crohn’s disease and ulcerative colitis —  that affects more than a million people in the United States. Normally,...

The exact causes of Crohn’s disease remain a mystery, but scientists do know that genetic factors play an important part. More than 30 variations have been associated with increased risk...

SNPwatch gives you the latest news about research linking various traits and conditions to individual genetic variations. These studies are exciting because they offer a glimpse into how genetics may...

A large international collaboration of researchers has tripled the number of SNPs associated with Crohn’s disease, an inflammatory bowel disease that affects about 500,000 Americans. Their results were published online...